KamTek
- Company typePrivate
- Founded1992
- HeadquartersFrederick, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
KamTek firmographics
Firmographics- Name
- KamTek
- Legal name
- KamTek, Inc.
- Website
- https://kamtekinc.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where KamTek is headquartered
LocationHeadquarters
- HQ city
- Frederick
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
KamTek business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Biorepository Services: Comprehensive biospecimen storage services across multiple temperature ranges (RT to -196°C), including long-term archival storage, short-term research storage, clinical study storage, and disaster recovery backup storage. Revenue generated through storage fees based on volume, temperature requirements, and duration.
- Laboratory Services: Advanced laboratory processing including cellular services, molecular biology, microbiology, and sample processing. Services include PBMC isolation, EBV transformation, DNA/RNA extraction, PCR testing, and custom assays. Revenue generated through per-service fees and project-based contracts.
- Stability Storage and Testing: ICH Q1A (R2) and ICH Q1B compliant stability storage and testing services for pharmaceutical products, biologics, and drug substances. Includes long-term, intermediate, accelerated, refrigerated, freezer, and photo stability testing. Revenue through study-based contracts with periodic pulls and testing.
- Sample Management and Logistics: Sample receipt, inventory management, custom kitting, and distribution services including cold chain logistics and international shipping. Revenue from kitting services, inventory management fees, and shipping/logistics coordination.
- Sample Disposal Services: Compliant disposal of biological samples, hazardous materials, documents, and equipment with certified destruction reports. Revenue generated through disposal service fees based on volume and material type.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
KamTek product offering
Product offeringCore offering
KamTek provides cGMP-compliant, ISO 9001:2015 certified biorepository and laboratory services for life sciences and government clients. Core offerings include secure multi-temperature biospecimen storage (Room Temperature to -196°C liquid nitrogen), ICH Q1A and ICH Q1B stability storage and testing, cellular services (PBMC isolation, EBV transformation), molecular biology (DNA/RNA extraction, real-time PCR), and microbiology (aerobic/anaerobic culture, antimicrobial testing). Supporting services include custom kitting, inventory management, IATA-compliant cold chain distribution, and compliant sample disposal.
Product overview
KamTek offers a unified, end-to-end biospecimen management platform comprising core biorepository services (Bio Storage, ICH Stability Storage, ICH Photo Stability Storage) supplemented by laboratory services modules (Cellular Services, Molecular Biology Services, Microbiology Services, Sample Processing Services) and logistics/add-on services (Product Distribution, Custom Kitting, Inventory Management, Sample Disposal). The platform is designed to support the complete biospecimen lifecycle from sample receipt through secure storage, processing, distribution, and compliant disposal, serving pharmaceutical, biotech, government, and academic clients.
Differentiator
Problem solved
Functional benefit
Products and services
- Bio Storage (Biorepository Services) Secure, 24/7-monitored storage of biological specimens across six temperature ranges (Room Temperature, 4°C, -20°C, -80°C, -170°C, -196°C liquid nitrogen) with redundant backup systems; serves pharma, biotech, government, and academic clients requiring long-term or short-term biospecimen retention and disaster recovery backup storage.
- ICH Stability Storage ICH Q1A (R2)-compliant stability storage and testing services for drug substances and drug products, covering long-term, intermediate, accelerated, refrigerated, and freezer stability studies at precise temperature and humidity conditions (25°C/60% RH, 30°C/65% RH, 40°C/75% RH); targets pharmaceutical sponsors and CMOs requiring regulatory-grade stability data.
- ICH Photo Stability Storage ICH Q1B-compliant photostability storage and testing delivering ≥1.2 million lux-hours total light exposure and ≥200 Wh/m² near-UV energy with continuous temperature and humidity monitoring; designed for pharmaceutical clients assessing light-induced degradation profiles of drug substances and drug products.
- Cellular Services Laboratory services for live cell materials including PBMC isolation and cryopreservation, EBV transformation of PBMCs, mycoplasma testing, cell line culture and expansion, and cell-based immunoassays; serves biotech, academic, and clinical research clients needing specialized cell handling without in-house infrastructure.
- Molecular Biology Services DNA/RNA extraction, nucleic acid stabilization and storage, real-time PCR gene quantification, nucleic acid quantification and aliquoting, and preparation for downstream applications including PCR and sequencing; supports biotech, pharma, and academic researchers requiring validated molecular workflows.
- Microbiology Services Anaerobic and aerobic microbe culture and expansion, in vitro efficacy testing of antimicrobial agents, bacterial and fungal spore production, and microbiome studies for infectious disease research, antimicrobial development, and gut-microbiome programs.
- Sample Processing Services Custom and high-throughput biospecimen processing including aliquoting (serum, plasma, drug, culture), labeling, barcoding, accessioning, plasma-to-serum defibrination, and immunoassays/ELISA; supports clinical trial and diagnostic workflows requiring scalable, traceable sample handling.
- Product Distribution (Shipping) Secure, DOT- and IATA-compliant global shipping of biospecimens and clinical materials, including frozen, ambient, and cryogenic shipments with temperature monitoring and real-time tracking; supports clinical trial material distribution and study-site logistics.
- Custom Kitting End-to-end custom kit assembly for clinical trials, research, and diagnostics including component sourcing, assembly, labeling, QC, and global distribution under ISO-certified, FDA-registered, and cGMP-compliant standards; targets clinical trial sponsors and diagnostic programs.
- Inventory Management Scalable, high-accuracy biospecimen inventory management including full sample cataloging, manifest generation, barcode and label verification, slide and block logging, and physical/digital reconciliation; powered by an in-house inventory platform with LIMS integration.
- Sample Disposal Compliant disposal of biological samples, hazardous materials, documents, formalin waste, surplus lab equipment, and mixed waste with certificate of destruction; provides end-of-life closure for biorepository and laboratory programs.
Quantifiable outcome
- 20 million+ samples successfully handled without compromise to quality or security
- +7 more outcomes
Companies that use KamTek
Customer profileNamed customers25 records
Segments7 records
Ideal customer profiles2 records
KamTek technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature11 records
KamTek partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, secondary and supporting.
- University of Maryland School of Pharmacy (UMSOP)coreCollaboration on therapeutic development to treat deadly infections, specifically the EK101 Clofazimine formulation for CDI treatment. KamTek's microbiology labs investigated antimicrobial selectivity and discovered potent narrow-spectrum activity of Clofazimine against C. difficile, with research findings published and translated into therapeutic development.
- George Washington Hospital (Dr. Raja Mazumder's Lab)secondaryCollaboration on microbiome and metagenomics research studying how gut microbiota influences health and treatment outcomes for C. difficile-associated disease. Analyzed 160 fecal samples from healthy individuals using NGS-based metagenomic analysis.
- FedExsupportingLogistics partner for domestic and international shipments of biospecimens and clinical materials, including frozen, ambient, and cryogenic shipments.
- World CouriersupportingSpecialized logistics partner for temperature-controlled and critical shipments of research and clinical materials.
- UPSsupportingLogistics partner for domestic and international shipments of biospecimens and clinical materials.
- T-forcesupportingLogistics partner for temperature-controlled and critical shipments.
- DHLsupportingInternational logistics partner for global distribution of biospecimens and clinical materials.
- NCIsecondaryCollaborated on Leishmania PCR and custom microarray development through SBIR-funded Phase I & II research, generating peer-reviewed publications.
- WRAIR (Walter Reed Army Institute of Research)secondaryCollaborated on Leishmania diagnostics and molecular diagnostics research, contributing to peer-reviewed publications.
- U.S. NavysecondaryCollaborated on molecular diagnostics and microarray research for infectious disease detection.
- Ariosa Diagnostics (now Roche Sequencing Solutions)secondaryProvided trisomy 18 cell lines from cord blood foundational for Harmony Prenatal Test development, a widely adopted non-invasive blood screening tool.
Scale indicators19 records
Recent moves6 records
Expansion highlights5 records
KamTek competitors and assessment
Company assessmentDirect peers
- BioIVT: BioIVT provides biospecimen procurement, processing, storage, and distribution for pharma, diagnostics, and academic research. Like KamTek, it emphasizes chain-of-custody, multi-temperature storage, and donor-sample lifecycle services, making it a head-to-head competitor in biospecimen management.
- Cryoport Systems: Cryoport provides temperature-controlled cold-chain logistics and biostorage for cell and gene therapies, including cryogenic shipping, biorepository, and chain-of-custody solutions. It is highly comparable to KamTek's logistics + biorepository offering, particularly in clinical trial distribution.
- Azenta Life Sciences (formerly Brooks Life Sciences): Azenta is the largest dedicated biorepository and cold-chain sample management provider globally, offering multi-temperature storage, ICH stability, sample logistics, and LIMS-integrated inventory. It is the closest direct competitor to KamTek, serving the same pharma, biotech, and academic customers at significantly larger scale.
- Cellero (formerly HemaCare): Cellero specializes in primary cells, PBMCs, cryopreservation, and cell-processing services for cell therapy and immuno-oncology research. Its cryopreservation and cellular services for clinical/biotech use cases overlap materially with KamTek's cellular services and -196°C storage.
- Precision for Medicine (Precision BioServices): Precision for Medicine offers integrated biorepository, biomarker, and biospecimen management services supporting clinical trials and translational research. Its biorepository and processing capabilities overlap directly with KamTek's core offerings for pharma and government clients.
Broad incumbents
- WuXi AppTec / WuXi Biologics: WuXi AppTec is a global CRO/CDMO with extensive biorepository, biospecimen, and stability storage operations. While broader in scope than KamTek, it competes for the same biopharma stability-storage and sample management RFPs and represents a larger incumbent alternative.
- IQVIA Laboratories / Q² Solutions: IQVIA (through Q² Solutions) operates central labs and biorepository services supporting global clinical trials, including multi-temperature storage and stability studies. It is a broader incumbent offering similar services as part of a much larger clinical-research portfolio.
- Labcorp Central Labs / Covance: Labcorp/Covance provides central laboratory, biorepository, and stability storage services for clinical trials and drug development. While broader and global in scale, it competes with KamTek for bioanalytical and sample-management contracts from large pharma.
Others
- BioLife Solutions: BioLife Solutions is a supplier of cryopreservation media, storage tools, and cold-chain consumables used in cell and gene therapy biopreservation. It is comparable as an ecosystem participant supplying preservation technologies into workflows that KamTek also serves.
Regional players
- Cell & Gene Therapy Catapult: Cell & Gene Therapy Catapult operates UK-based manufacturing, storage, and logistics infrastructure for advanced therapies, including cryogenic storage. It is a regional peer offering comparable biorepository and cold-chain services to cell therapy developers in Europe.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks6 records
Key highlights7 records
Customer concentration
KamTek social profiles
Digital presenceKamTek compliance and trust
Trust signalCompliance7 records
KamTek financial estimates
Financial estimateRevenue estimate
Valuation estimate
KamTek leadership team
Management profileNumber of profiles
Profiles5 records
KamTek funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KamTek M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KamTek
What does KamTek do?
KamTek provides cGMP-compliant, ISO 9001:2015 certified biorepository and laboratory services for life sciences and government clients. Core offerings include secure multi-temperature biospecimen storage (Room Temperature to -196°C liquid nitrogen), ICH Q1A and ICH Q1B stability storage and testing, cellular services (PBMC isolation, EBV transformation), molecular biology (DNA/RNA extraction, real-time PCR), and microbiology (aerobic/anaerobic culture, antimicrobial testing). Supporting services include custom kitting, inventory management, IATA-compliant cold chain distribution, and compliant sample disposal.
Is KamTek a public or private company?
KamTek is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was KamTek founded?
KamTek was founded in 1992. It employs 11 to 50 people.
Where is KamTek based?
KamTek is headquartered in Frederick, United States, in the North America region.
How does KamTek make money?
Five revenue lines are on record. Biorepository Services are the primary driver. The others are laboratory Services, stability Storage and Testing, sample Management and Logistics and sample Disposal Services.
Who are KamTek's main competitors?
Direct peers on record are BioIVT, Cryoport Systems, Azenta Life Sciences (formerly Brooks Life Sciences), Cellero (formerly HemaCare) and Precision for Medicine (Precision BioServices). Broad incumbents are WuXi AppTec / WuXi Biologics, IQVIA Laboratories / Q² Solutions and Labcorp Central Labs / Covance. BioLife Solutions is listed as an others. Cell & Gene Therapy Catapult is listed as a regional player.
Does KamTek have an API?
No public API is recorded for KamTek.